Compare TEVA & NTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | NTR |
|---|---|---|
| Founded | 1901 | 2017 |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 26.6B |
| IPO Year | N/A | N/A |
| Metric | TEVA | NTR |
|---|---|---|
| Price | $30.30 | $61.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 17 |
| Target Price | $29.78 | ★ $63.76 |
| AVG Volume (30 Days) | ★ 10.6M | 2.6M |
| Earning Date | 01-28-2026 | 11-05-2025 |
| Dividend Yield | N/A | ★ 3.47% |
| EPS Growth | N/A | ★ 150.34 |
| EPS | 0.62 | ★ 3.70 |
| Revenue | $16,776,000,000.00 | ★ $25,671,000,000.00 |
| Revenue This Year | $4.74 | $6.44 |
| Revenue Next Year | $0.48 | $1.26 |
| P/E Ratio | $48.27 | ★ $16.98 |
| Revenue Growth | 0.02 | ★ 0.45 |
| 52 Week Low | $12.47 | $43.70 |
| 52 Week High | $30.20 | $65.08 |
| Indicator | TEVA | NTR |
|---|---|---|
| Relative Strength Index (RSI) | 81.00 | 59.22 |
| Support Level | $28.00 | $58.04 |
| Resistance Level | $30.20 | $62.80 |
| Average True Range (ATR) | 0.66 | 1.43 |
| MACD | 0.16 | 0.32 |
| Stochastic Oscillator | 96.20 | 76.83 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients—nitrogen, potash, and phosphate—although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.